| Literature DB >> 26496480 |
Vera Jäger1, Matthias Dümpelmann2, Pierre LeVan3, Georgia Ramantani2, Irina Mader4, Andreas Schulze-Bonhage2, Julia Jacobs1.
Abstract
OBJECTIVE: The present study aims to investigate whether a newly developed fast fMRI called MREG (magnetic resonance encephalography) measures metabolic changes related to interictal epileptic discharges (IED). For this purpose BOLD changes are correlated with the IED distribution and variability.Entities:
Mesh:
Year: 2015 PMID: 26496480 PMCID: PMC4619722 DOI: 10.1371/journal.pone.0140537
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Exemplary illustration of the used methods.
(A) Determination of IED extent. The red circle indicates the IED with the highest negativity, the blue circle indicates IEDs with at least 50% of this negativity and the green circle indicates IEDs that did not meet the inclusion criteria. (B) Representation of possible inter-spike variability within one IED set.
IED and BOLD extent.
| Patient | Spiketype | Electrode with maximum spike negativity | Electrodes with ≥ 50% of maximum spike negativity | Number of involved electrodes | Positive BOLD volume in cm³ | Number of positive BOLD clusters | Cluster with max T-value |
|---|---|---|---|---|---|---|---|
|
| Spike 1 | TP10 | TP8, FT8, FT6, T8, CP6 | 5 | 3928 | 18 | 308 |
| Spike 2 | F8 | FP2, AF8, F6, FT8, T8 | 5 | 3688 | 17 | 2079 | |
|
| Spike 1 | FP2 | FP1, AF4, AF8, FZ, F2, F4, F6, CPz | 8 | 4684 | 24 | 3781 |
|
| Spike 1 | C4 | FC6 | 1 | 1783 | 17 | 446 |
| Spike 2 | F3 | FP1, AF7, AF3, F7, F5, F1, F2, F4, FT9, TP7, P3, O1 | 12 | 4065 | 8 | 2961 | |
|
| Spike 1 | FP2 | FP1, F3, F4, | 3 | 1643 | 8 | 427 |
| Spike 2 | C1 | FP1, AF7, AF3, F7, F5, F3, FT7, FC5, FC3, FC1, C5, C3, Cz, CP2, CPz, CP1, CP3, Pz | 3 | 3740 | 31 | 327 | |
| Spike 3 | FP2 | FP1, F4 | 2 | 2152 | 15 | 898 | |
|
| n.a. | ||||||
|
| Spike 1 | C3 | C5, C1, CP3, FC1, FC3 | 5 | 744 | 16 | 59 |
| Spike 2 | TP9 | FT9, FT7, FC5, CP5 | 4 | 8879 | 28 | 8107 | |
| Spike 3 | FT7 | FT9, FC5, T7, C5, TP9, TP7, CP5, POz, TP10 | 9 | 2285 | 17 | 1152 | |
| Spike 4 | C5 | T7, C3, FT9, FT7, FC5, FC3, F7, AF7, TP7, CP5, CP3 | 11 | 7156 | 21 | 6687 | |
|
| Spike 1 | T7 | FT9, FT7, TP9 | 3 | 2382 | 18 | 823 |
|
| Spike 1 | FP2 | FP1, F3, C3 | 3 | 741 | 18 | 114 |
| Spike 2 | POz | TP10, CP6, CP2, CP1, CP5, TP9, FC5, FC6 | 8 | 1453 | 14 | 319 | |
|
| Spike 1 | F3 | C3 | 1 | 2320 | 22 | 1084 |
| Spike 2 | POz | TP9, TP10, CP5, CP1, CP2,CP6, FC6, FC5 | 8 | 3313 | 20 | 2017 | |
| Spike 3 | TP9 | TP10, CP6, CP5, CP2, FC5, FC6, Poz | 7 | 358 | 10 | 154 | |
|
| Spike 1 | F7 | AF7, AF3, F5, F3, FC3, FC5, FT7, FT9 | 8 | 2020 | 25 | 12 |
| Spike 2 | TP9 | FT9, FT7, T7, TP7, P7 | 5 | 3118 | 40 | 25 | |
| Spike 3 | TP10 | T8, TP8, | 2 | 2110 | 28 | 795 | |
|
| Spike 1 | T8 | TP10, CP6, P8, C6, FT10, FT8, FC6, F8, Oz, O2 | 10 | 1920 | 36 | 725 |
|
| Spike 1 | FT9 | AF4, AF7, FPz, FP2, F7, F5, F3, FT7 | 8 | 3970 | 37 | 270 |
| Spike 2 | FP1 | F3, F4, C3, C4 | 4 | 278 | 15 | 52 | |
|
| n.a. | ||||||
|
| Spike 1 | AF7 | FP1, FPz, FP2, AF3, AF4, F7, F5, F3, F1, FZ, F2, F4, FT9, FT7, FC5, FC3, FC1, FC2, | 18 | 11264 | 71 | 2859 |
|
| Spike 1 | FT10 | FT8, FC6, FC4, F8, F6, F4, AF4, FP2, T8, C6 | 10 | 8401 | 28 | 5567 |
| Spike 2 | TP9 | FT9, TP7,T7, P7, P5, P3 | 6 | 12966 | 19 | 12537 | |
| Spike 3 | P4 | P2, P6, CP2, PO4 | 4 | 0 | 0 | 0 | |
|
| Spike 1 | FPz | FP1, FP2, AF7, AF3 | 4 | 1602 | 19 | 187 |
| Spike 2 | F2 | FP1, FP2, AF7, AF3, AF4, AF8, F7, F5, F3, F1, Fz, F4, F6, F8, FT7, FC5, FC3, FC1, FC2, FC4, FC6, FT8, C5 | 23 | 1681 | 12 | 558 | |
|
| Spike 1 | F5 | FP1, FP2, AF7, AF3, AF4, F3, F1, F2, FC5, FC3, FC1, C3, Cz, CP3 | 14 | 2883 | 16 | 1554 |
| Spike 2 | FT9 | FP1, FPz, FP2, AF7, AF3, F7, F3, FT7 | 8 | 3825 | 24 | 1378 |
AF, anteriofrontal; C, central; CP, centroparietal; F, frontal; FC, frontocentral; FP, frontoparietal; FT, frontotemporal; n.a., not available; O, occipital; P, parietal; PO, parietooccipital; T, temporal; TP, temporoparietal; z, central
Fig 2Example 1 for better representation of the BOLD-topography with 64 electrodes.
27-year-old patient (patient 6, study 3) with left structural frontal lobe epilepsy. The patient underwent a previous operation with frontal resection, which showed a FCD type 2a. No seizure freedom could be achieved through operation. This is a typical example for the superiority of the 64-channel-EEG. The 32-channel EEG reveals a left temporoparietal IED area (A). The 64-channel EEG shows that left frontotemporal regions are as well included in the IED area (B.) The extensive positive BOLD response on the left hand side exactly reflects the IED distribution from temporoparietal to frontotemporal as shown in the 64-channel EEG. The white arrow indicates the relevant positive BOLD response (C and D). (E) shows different IEDs of one IED set.
Clinical information.
| Patient | Age | m/f | Age of onset | Epilepsy classification | Seizure types | Inter-ictal EEG | MRI | PET/SPECT | AED | Surgery outcome |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 36 | m | 7 y | Structural TLE | CPS | F+T right | MTS right | n.a. | LTG LCM | n.a |
| 2 | 26 | m | 7 y | Structural TLE | CPS | FT bilateral > FT left | Hypothalamic hamartoma | PET: discrete hypometabolism P, T right | LEV OXC LCM | Seedtherapy:not seizure free |
| 3 | 17 | f | 16 y | Structural TLE | CPS | T + TP right; T left | Unclear mass in the left superior T gyrus | n.a. | OXC | n.a. |
| 4 | 17 | m | 13 y | Unclear | SPS/CPS GTCS | PO bilateral | Normal | PET: discrete hypometabolism P left | LTG OXC | n.a. |
| 5 | 27 | f | 16 y | FLE of unclear origin | CPS/GTCS | F bilateral | Normal | PET: normal | LTG LEV | n.a. |
| 6 | 27 | m | 11 y | Structural FLE | SPS/CPS GTCS | FC, FT left | Surgical cavity left F | PET: extensive hypometabolism TP left | LEV OXC | surgery: not seizure free |
| 7 | 12 | m | 9 y | Structural FLE | CPS | F bilateral; T left | Cavernoma F right | n.a. | none | n.a. (surgery) out? |
| 8 | 9 | m | 4 y | Structural FLE | SPS/CPS GTCS | FC bilateral T bilateral | Extensive right polymicrogyria | PET: hypometabolism F, P left | LEV VPA | n.a. |
| 9 | 28 | f | 11 y | FLE of unclear origin | SPS/CPS GTCS | FP-FC right TP right | Unclear lesion right, F including insular cortex | PET/SPECT: hypometabolism F right | LTG LCM | surgery: not seizure free |
| 10 | 71 | m | 70 y | Structural TLE | CPS | T pole right | Cystic tumor mesio temporal left | n.a. | VPA | n.a. surgery? |
| 11 | 31 | f | 31 y | TLE of unclear origin | CPS | T right | n.a. | n.a. | OXC | n.a. |
| 12 | 60 | m | 40 y | unclear | CPS | T bilateral F bilateral | Defect/gliosis T pole left | PET: hypo metabolism T left | OXC | n.a. |
| 13 | 13 | m | 3 y | Structural TLE | CPS/GTCS | CP bilateral T bilateral | MTS left and gliosis TP | n.a. | VPA LEV | n.a. |
| 14 | 23 | m | n.a. | unclear | SPS/CPS GTCS | T right > T left F left O right | abnormal gyration O right | n.a. | LTG CLO | n.a. |
| 15 | 39 | f | 23 y | TLE of unclear origin | CPS | T bilateral | Hippocampus malrotation left | PET: normal | LTG | n.a. |
| 16 | 13 | f | 7 y | unclear | CPS/GTCS | FC bilateral; F left | FCD medial-basal right | PET: normal | CAB VPA | n.a. |
| 17 | 15 | m | 12 y | unclear | SPS/CPS GTCS | FC bilateral P left | n.a. | PET: hypometabolism F left | LTG | n.a. |
AED, anti epileptic drug; C, central; CAB, carbamazepine; CLO, clobazam; CPS, complex partial seizure; f, female; F, frontal; FC, frontocentral; FLE, frontal lobe epilepsy; FP, frontopolar; FT, frontotemporal;GTCS, generalized tonic clonic seizure; LCM, lacosamide; LEV, levetiracetam; LTG, lamotrigine; m, male; MTS, mesial temporal sclerosis; n.a., not available; O, occipital; OXC, oxcarbazepine; P, parietal; SPS, simple partial seizure; T, temporal; TLE,temporal lobe epilepsy; TP, temporoparietal; VPA, valproate acid; y, year
Fig 3Example for correlation between PET and positive BOLD response.
26 year old patient (patient 2) with structural epilepsy. PET shows a discrete temporal and parietal hypometabolism. The strongest positive BOLD response in MREG is located temporal on the right hand side and therefore shows a good correlation with PET.
Fig 4Representation of the positive correlation between IED and BOLD extent.
The x-axis shows the in the IED extent included number of electrodes. The y-axis once shows the volume of positive BOLD responses (A) and once the number of positive BOLD clusters (B) in MREG. Patient 8, study 1 reveals a restricted frontal IED area in the EEG (C), concordant to the left focal positive BOLD response in MREG (E). Only few other clusters are visible, all of them focal. In comparison, patient 16, study 2 reveals a widespread IED area in the EEG (D) with the highest negativity over F2 and multiple, widespread BOLD clusters in MREG (F). However, the BOLD response located at the front is concordant to the most negative IED area over F2 and the MRI results.
Fig 5Example 2 for better representation of the BOLD-topography with 64 electrodes.
71-year-old patient (patient 10, study 3) with structural temporal lobe epilepsy. Another example for the predominance of the 64-channel-EEG. The 32-channel EEG reveals a temporoparietal IED area (A). The 64-channel EEG shows that the IED area as well spreads into frontotemporal regions (B). The positive BOLD response on the right hand side represents the IED distribution from temporoparietal to frontal regions as shown in the 64-channel EEG. The white arrow indicates the relevant positive BOLD response (C and D).
Detailed representation of BOLD effects and comparison between 32/64 channel EEG.
| positive BOLD | negative BOLD | ||||||
|---|---|---|---|---|---|---|---|
| Spike topography | 32 electrodes | Comparison 32/64 | 64 electrodes | 32 electrodes | Comparison 32/64 | 64 electrodes | |
|
| TP right | + | = | + | − | − | |
| T right | + | = | + | − | − | ||
|
| Fp right | + | = | + | + | = | + |
|
| CP right | − | − | − | − | ||
| F left | + | = | + | − | − | ||
|
| Fp right | + | = | + | − | − | |
| C left | − | − | + | = | + | ||
| Fp right | + | = | + | − | − | ||
|
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
|
| C left | + | = | + | − | − | |
| TP left | + | = | + | − | − | ||
| FT left | + | < | + | − | − | ||
| C left | + | = | + | − | − | ||
|
| T left | − | − | − | − | ||
|
| Fp right | + | = | + | − | − | |
| PO central | + | = | + | − | − | ||
|
| F left | − | − | + | = | + | |
| PO central | − | − | + | = | + | ||
| TP left | + | = | + | − | − | ||
|
| F left | − | − | − | − | ||
| TP left | + | = | + | − | − | ||
| TP right | − | < | + | − | − | ||
|
| FT right | + | < | + | − | − | |
|
| FT left | − | − | + | > | − | |
| Fp left | − | − | + | = | + | ||
|
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
|
| F left | − | − | − | < | + | |
|
| FT right | − | − | + | < | + | |
| TP left | + | = | + | − | − | ||
| P rigth | − | − | − | − | |||
|
| Fp central | + | < | + | − | − | |
| F right | + | = | + | − | − | ||
|
| F left | − | − | − | − | ||
| FT left | − | − | − | − | |||
|
|
|
|
|
|
|
| |
C, central; CP, centroparietal; F, frontal; FC, frontocentral; FP, frontoparietal; FT, frontotemporal; n.a., not available; P, parietal; PO, parietooccipital; T, temporal; TP, temporoparietal; +, concordance between BOLD and spike topography; -, no concordance between BOLD and spike topography; <, predominance of the 64-channel-EEG; >, predominance of the 32-channel EEG; = or free field, there was no difference between the 32- and the 64-channel map.